Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+7.65%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$8.27B
AUM Growth
+$1.17B
(+17%)
Cap. Flow
+$750M
Cap. Flow
% of AUM
9.07%
Top 10 Holdings %
Top 10 Hldgs %
43.67%
Holding
1,071
New
101
Increased
574
Reduced
272
Closed
122
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$287M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
$258M |
| 3 |
Apple
AAPL
|
$67.9M |
| 4 |
Microsoft
MSFT
|
$62.7M |
| 5 |
iShares China Large-Cap ETF
FXI
|
$59.7M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$189M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$112M |
| 3 |
Visa
V
|
$56.8M |
| 4 |
Mastercard
MA
|
$50M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$42.1M |
Sector Composition
| 1 | Technology | 27.51% |
| 2 | Financials | 14.83% |
| 3 | Healthcare | 4.08% |
| 4 | Consumer Discretionary | 3.56% |
| 5 | Industrials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Otis Worldwide
OTIS
$34.3B
| $727K | 0.01% |
+11,649
| New | +$727K |
|
627
AvalonBay Communities
AVB
$27.7B
| $723K | 0.01% |
4,841
-28,789
| -86% | -$4.3M |
|
628
Veeva Systems
VEEV
$46.3B
| $723K | 0.01% |
2,572
+700
| +37% | +$197K |
|
629
Realty Income
O
$54B
| $718K | 0.01% |
12,194
-72,291
| -86% | -$4.26M |
|
|
IBTX
630
DELISTED
Independent Bank Group, Inc.
IBTX
| $717K | 0.01% |
16,230
-5,576
| -26% | -$246K |
|
631
OneMain Financial
OMF
$7.27B
| $701K | 0.01% |
22,443
+9,067
| +68% | +$283K |
|
632
Alexandria Real Estate Equities
ARE
$14.6B
| $695K | 0.01% |
4,341
-25,505
| -85% | -$4.08M |
|
633
Catalyst Pharmaceutical
CPRX
$2.46B
| $693K | 0.01% |
233,330
+148,429
| +175% | +$441K |
|
634
HCA Healthcare
HCA
$97.8B
| $692K | 0.01% |
5,553
-376
| -6% | -$46.9K |
|
635
American Electric Power
AEP
$57.5B
| $687K | 0.01% |
8,405
-3,904
| -32% | -$319K |
|
|
RDUS
636
DELISTED
Radius Health, Inc.
RDUS
| $683K | 0.01% |
60,199
+31,091
| +107% | +$353K |
|
637
Enanta Pharmaceuticals
ENTA
$190M
| $678K | 0.01% |
14,808
+5,759
| +64% | +$264K |
|
|
FLXN
638
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $674K | 0.01% |
64,768
+34,851
| +116% | +$363K |
|
639
CBRE Group
CBRE
$48.7B
| $672K | 0.01% |
14,307
-66,352
| -82% | -$3.12M |
|
|
CADE
640
DELISTED
Cadence Bancorporation
CADE
| $671K | 0.01% |
78,162
+13,663
| +21% | +$117K |
|
|
ATHX
641
DELISTED
Athersys, Inc. Common Stock
ATHX
| $664K | 0.01% |
13,619
+7,615
| +127% | +$371K |
|
|
KAMN
642
DELISTED
Kaman Corp
KAMN
| $660K | 0.01% |
+16,927
| New | +$660K |
|
643
Rocket Companies
RKT
$43.1B
| $656K | 0.01% |
+32,920
| New | +$656K |
|
644
Sturm, Ruger & Co
RGR
$576M
| $655K | 0.01% |
10,705
+1,502
| +16% | +$91.9K |
|
645
Agilent Technologies
A
$36.3B
| $653K | 0.01% |
6,474
-1,296
| -17% | -$131K |
|
646
Beazer Homes USA
BZH
$773M
| $651K | 0.01% |
49,283
+7,914
| +19% | +$105K |
|
647
Rigel Pharmaceuticals
RIGL
$733M
| $650K | 0.01% |
+27,073
| New | +$650K |
|
648
Ventas
VTR
$30.9B
| $650K | 0.01% |
15,502
-101,381
| -87% | -$4.25M |
|
|
CTLT
649
DELISTED
CATALENT, INC.
CTLT
| $646K | 0.01% |
7,542
+3,101
| +70% | +$266K |
|
650
Revolution Medicines
RVMD
$7.68B
| $643K | 0.01% |
+18,483
| New | +$643K |
|